<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-150720</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Corinebacterium urealyticum: increased incidence of infection and encrusted uropathy</dc:title>
<dc:description xml:lang="en">Introduction: Corynebacterium urealyticum (CU) affects patients who are immunosuppressed, chronically ill or have undergone numerous operations. Obstructive uropathy (OU) is a complication of infection. Study objective: To demonstrate the growing increase in cases of infection by CU and OU in the past 5 years. Material and methods: A descriptive study was conducted of urological patients with CU-positive urine cultures (January 2009-December 2014). We calculated the annual distribution and clinical characteristics of infection by CU and OU. Minimum follow-up: 6 months. We obtained the statistical means and ranges of clinical parameters pre/post-therapy. Results: The total number of patients with CU was 115 (men, 87; women, 28). The mean age was 67.9 years (range, 6-95 years), and the annual distribution of cases for 2009, 2010, 2011, 2012, 2013 and 2014 was 9 (7.8%), 13 (11.3%), 9 (7.8%), 20 (17.4%), 31 (27%) and 33 (28.7%), respectively. The increase in cases for 2009&#150;2014 was 300%. Multiple urological surgeries were performed in 89 cases (77.3%), with surgical complications in 77 cases (66.9%). Eighteen (15.6%) patients had OU (men, 13; women, 5), 12 had pyelitis (66.7%), 3 had cystopathy (16.6%), 2 had prostatic capsule disease (11.2%) and 1 had mesh calcification (5.5%). The analysis of the 18 cases with OU showed pre/postantibiotic therapy urine pHs of 8 (r, 6&#150;9) vs. 6 (r, 5&#150;7). All postantibiotic cultures were negative. Acidifying solution was applied in 5 cases, and surgery was performed in 13 cases (72.2%). The results from before/after the multimodal therapy showed renal impairment in 12 (66.6%) vs. 9 cases (50%) and glomerular filtration rates (GFR) of 45.8 (r, 6&#150; &gt; 90) vs. 52.7 (r, 13&#150; &gt; 90). The improvement in GFR was 6.94 points (T Wilcoxon; P = .102). The radiology results (incrustations) showed improvement in 13 patients (72.2%) and no change in 5 (27.8%). There was no specific mortality for CU. Conclusions: The prevalence of infection by CU and OU is increasing. Antibiotic treatment is highly effective. Acidifying solutions are an acceptable option for reducing calcifications (AU)</dc:description>
<dc:creator>Kanashiro Azabache, A</dc:creator>
<dc:creator>Moncada, E</dc:creator>
<dc:creator>Millán Rodríguez, F</dc:creator>
<dc:creator>Villavicencio-Mavrich, H</dc:creator>
<dc:creator>López Martínez, JM</dc:creator>
<dc:creator>Angerri Feu, O</dc:creator>
<dc:creator>Sánchez Martín, FM</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Corynebacterium urealyticum (CU) afecta a pacientes inmunodeprimidos, crónicos o multioperados. La uropatía incrustante (UI) representa una complicación de la infección. Objetivo del estudio: demostrar el aumento creciente de casos de infección por CU y UI en los últimos 5 años. Material y métodos:  Estudio descriptivo de pacientes urológicos con urocultivo positivo a CU (enero de 2009-diciembre de 2014). Cálculo de distribución anual y características clínicas de infección por CU y UI. Seguimiento mínimo: 6 meses. Obtención de medias y rangos estadísticos de parámetros clínicos pre/postratamiento. Resultados: Total de pacientes con CU: 115 (hombres 87: mujeres 28). Edad: 67,9 años (rango 6-95). Distribución anual (casos) 2009: 9 (7,8%), 2010: 13 (11,3%), 2011: 9 (7,8%), 2012: 20 (17,4%), 2013: 31 (27%), 2014: 33 (28,7%). Incremento 2009-2014: 300%. Cirugía urológica múltiple: 89 casos (77,3%). Complicaciones quirúrgicas: 77 casos (66,9%). Pacientes con UI: 18 casos (15,6%) (hombres 13: mujeres 5): pielitis 12 (66,7%), cistopatía 3 (16,6%), prostatic capsule disease 2 (11,2%), calcificación de la malla uno (5,5%). Análisis de 18 casos con UI: PH orina pre/postantibiótico: 8 (r = 6-9) vs 6 (r = 5-7). Cultivo negativo postantibiótico: 100%. Aplicación de solución acidificante: 5 casos. Cirugía: 13 casos (72,2%). Resultados pre/postratamiento multimodal: insuficiencia renal: 12 (66,6%) vs 9 (50%), filtrado glomerular (FG): 45,8 (r = 6- &gt; 90) vs 52,7 (r = 13- &gt; 90). Mejoría del FG: 6,94 puntos (T Wilcoxon p = 0,102). Radiología (incrustaciones): mejoría 13 (72,2%), igual 5 (27,8%). No mortalidad específica por CU. Conclusiones: La prevalencia de infección por CU y la UI está aumentando. El tratamiento antibiótico es muy eficaz. Las soluciones acidificantes son una opción aceptable para reducir calcificaciones (AU)</dc:description>
<dc:source>Actas Urol Esp;40(2): 102-107, mar. 2016. tab, graf</dc:source>
<dc:identifier>ibc-150720</dc:identifier>
<dc:title xml:lang="es">Corynebacterium urealyticum: aumento de la incidencia de infección y uropatía incrustante</dc:title>
<dc:subject>^d14952^s22016</dc:subject>
<dc:subject>^d14952^s22027</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12138^s22016</dc:subject>
<dc:subject>^d12138^s22027</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d51782^s22054</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d51782^s22020</dc:subject>
<dc:subject>^d12138^s22054</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d12138^s22012</dc:subject>
<dc:subject>^d12138^s22067</dc:subject>
<dc:subject>^d14952^s22012</dc:subject>
<dc:subject>^d14952^s22067</dc:subject>
<dc:subject>^d14952^s22054</dc:subject>
<dc:type>article</dc:type>
<dc:date>201603</dc:date>
</metadata>
</record>
</ibecs-document>
